Trial Profile
A phase II trial to investigate the efficacy and safety of RG7697 in patients with type 2 diabetes
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2014
Price :
$35
*
At a glance
- Drugs RG 7697 (Primary) ; Liraglutide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 04 Dec 2014 According to the Roche pipleine, recruitment began in the third quarter of 2014.
- 04 Dec 2014 New trial record